-
Novel Value Elements: Developing and Applying a Pragmatic Framework in Early Stages of Product Development
Mar 10, 2025, 14:00 PM -
Development of New Patient Reported Outcome (PRO) Conceptual Models for Treatment Adherence and Satisfaction in People with HIV
Mar 10, 2025, 14:00 PM -
Training and Validation of CARAaiTM: A Multi LLM Platform and Data Model to Address Oncology-Specific Challenges in Clinical Data Extraction
Mar 10, 2025, 14:00 PM -
Estimating Costs Of Dispensing Services In Community Pharmacies In Taiwan Using A Time-Driven Activity-Based Costing Approach
Mar 10, 2025, 14:00 PM -
Over 30 Years of Discrete Choice Experiment Studies in Health Economics: Systematic Review of Current Practice and Reflections on Evolving Practice
Mar 10, 2025, 14:00 PM -
Which Strategy is More Effective in Patients with Rheumatoid Arthritis (RA) and Metotrexate Failure: Adding Leflunomide or TNFi?
Mar 10, 2025, 14:00 PM -
An Economic Model to Evaluate the Impact of Formulary Tier Increases for Apixaban on the Incidence and Cost of Clinical Events in Patients with Non-Valvular Atrial Fibrillation in the United States
Mar 10, 2025, 14:00 PM -
Taletrectinib vs Entrectinib in ROS1-Positive (ROS1+) Non-Small Cell Lung Cancer (NSCLC): A Matching-Adjusted Indirect Comparison (MAIC)
Mar 10, 2025, 14:00 PM -
Examination of Factors Influencing Colorectal Screening Participation
Mar 10, 2025, 14:00 PM -
Cost Savings With Treosulfan and Fludarabine (Treo/Flu) vs. Busulfan and Fludarabine (Bu2/Flu) Conditioning Regimen in Patients Undergoing Allogeneic HSCT for Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)
Mar 10, 2025, 14:00 PM -
Uptake of national guidance for prescribing of SGLT-2 inhibitors for type 2 diabetes in the UK
Mar 10, 2025, 14:00 PM -
Hospital-Level Effects on Cardiovascular Monitoring Among Cancer Patients Treated with Cardio-Toxic Therapies
Mar 10, 2025, 14:00 PM -
A Descriptive Analysis of Key Findings From the 2024-2025 ISPOR Student Interest Survey
Mar 10, 2025, 14:00 PM -
Validation of Real-World Recurrence-Free Survival (rwRFS) and Distant Metastasis-Free Survival(rwDMFS) Endpoints in Early-Stage Melanoma
Mar 10, 2025, 14:00 PM -
Cost Effectiveness of Glofitamab for Relapsed or Refractory Diffuse Large B-Cell Lymphoma Patients in China
Mar 10, 2025, 14:00 PM -
Medical Record Review to Characterize the Foundational Insights and Costs Associated with Intracerebral Hemorrhage (ICH) Management Among Ticagrelor-Treated Patients
Mar 10, 2025, 14:00 PM -
Changes in the Prevalence of Diabetes Mellitus in Pregnancy : A Nationwide Analysis From Hungary
Mar 10, 2025, 14:00 PM -
Prenatal Exposure to Antiseizure Medications and Congenital Malformation Risk in Offspring:A Population-Based Study
Mar 10, 2025, 14:00 PM -
Cost-Effectiveness of Antiarrhythmic Drugs for Treating Paroxysmal or Persistent Atrial Fibrillation in China
Mar 10, 2025, 14:00 PM -
Discordance Between Apolipoprotein B (apoB) and LDL-Cholesterol (LDL-C) and Incident Hypertension Risk among Patients with and without Type 2 Diabetes (T2D): An Analysis of US Real-World Data
Mar 10, 2025, 14:00 PM
